nodes	percent_of_prediction	percent_of_DWPC	metapath
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—SNAI1—pancreatic cancer	0.00615	0.0665	CbGpPWpGaD
Gabapentin—BCAT1—Amino acid and derivative metabolism—ARG2—pancreatic cancer	0.00294	0.0319	CbGpPWpGaD
Gabapentin—CACNA2D2—Regulation of insulin secretion—GLP1R—pancreatic cancer	0.00257	0.0278	CbGpPWpGaD
Gabapentin—CACNA2D2—Regulation of insulin secretion—SLC2A2—pancreatic cancer	0.0024	0.0259	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—SMAD4—pancreatic cancer	0.00237	0.0256	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—TERT—pancreatic cancer	0.00203	0.0219	CbGpPWpGaD
Gabapentin—CACNA2D2—Integration of energy metabolism—GLP1R—pancreatic cancer	0.00202	0.0218	CbGpPWpGaD
Gabapentin—CACNA2D2—Integration of energy metabolism—SLC2A2—pancreatic cancer	0.00188	0.0204	CbGpPWpGaD
Gabapentin—CACNA2D2—Regulation of insulin secretion—GCG—pancreatic cancer	0.00178	0.0193	CbGpPWpGaD
Gabapentin—CACNA2D2—Integration of energy metabolism—GCG—pancreatic cancer	0.0014	0.0151	CbGpPWpGaD
Gabapentin—CACNA2D1—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—pancreatic cancer	0.00133	0.0144	CbGpPWpGaD
Gabapentin—CACNA2D2—Integration of energy metabolism—STK11—pancreatic cancer	0.00132	0.0142	CbGpPWpGaD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—PRLHR—pancreatic cancer	0.00121	0.013	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—MMP9—pancreatic cancer	0.00114	0.0123	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—SSTR3—pancreatic cancer	0.0011	0.012	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—SSTR1—pancreatic cancer	0.00106	0.0115	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—PPY—pancreatic cancer	0.00104	0.0112	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—PRLHR—pancreatic cancer	0.00103	0.0112	CbGpPWpGaD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—SSTR3—pancreatic cancer	0.00103	0.0111	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—SSTR2—pancreatic cancer	0.00102	0.011	CbGpPWpGaD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—SSTR1—pancreatic cancer	0.000983	0.0106	CbGpPWpGaD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—SSTR2—pancreatic cancer	0.000946	0.0102	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—MYC—pancreatic cancer	0.00094	0.0102	CbGpPWpGaD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—CCKBR—pancreatic cancer	0.000914	0.00988	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—SSTR3—pancreatic cancer	0.000878	0.0095	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—AHR—pancreatic cancer	0.000868	0.00939	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—SSTR1—pancreatic cancer	0.000842	0.00911	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—PPY—pancreatic cancer	0.000826	0.00893	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—SSTR2—pancreatic cancer	0.000811	0.00877	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—PRLHR—pancreatic cancer	0.000787	0.00851	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCKBR—pancreatic cancer	0.000783	0.00847	CbGpPWpGaD
Gabapentin—BCAT1—Validated targets of C-MYC transcriptional activation—TP53—pancreatic cancer	0.000772	0.00835	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—CNR2—pancreatic cancer	0.000746	0.00807	CbGpPWpGaD
Gabapentin—CACNA2D2—Arrhythmogenic Right Ventricular Cardiomyopathy—CTNNB1—pancreatic cancer	0.000741	0.00801	CbGpPWpGaD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—CNR2—pancreatic cancer	0.000692	0.00749	CbGpPWpGaD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—CCKAR—pancreatic cancer	0.000681	0.00737	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—SSTR3—pancreatic cancer	0.000669	0.00724	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—EZH2—pancreatic cancer	0.000655	0.00708	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—SSTR1—pancreatic cancer	0.000641	0.00694	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—PPY—pancreatic cancer	0.000629	0.0068	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PRSS1—pancreatic cancer	0.000624	0.00675	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—SSTR2—pancreatic cancer	0.000617	0.00668	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCK—pancreatic cancer	0.000609	0.00659	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CCKBR—pancreatic cancer	0.000596	0.00645	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CNR2—pancreatic cancer	0.000593	0.00642	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCKAR—pancreatic cancer	0.000584	0.00631	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—SST—pancreatic cancer	0.00058	0.00628	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—ARG2—pancreatic cancer	0.000541	0.00585	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—CNR1—pancreatic cancer	0.000536	0.00579	CbGpPWpGaD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—CNR1—pancreatic cancer	0.000497	0.00538	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—SCT—pancreatic cancer	0.000486	0.00526	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—TYMS—pancreatic cancer	0.000474	0.00513	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—TYMP—pancreatic cancer	0.000473	0.00511	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CCK—pancreatic cancer	0.000464	0.00502	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—SST—pancreatic cancer	0.000461	0.00499	CbGpPWpGaD
Gabapentin—ADORA1—GPCRs, Class A Rhodopsin-like—AGTR1—pancreatic cancer	0.000458	0.00495	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CNR2—pancreatic cancer	0.000452	0.00489	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—GLP1R—pancreatic cancer	0.000452	0.00489	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CCKAR—pancreatic cancer	0.000444	0.00481	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CNR1—pancreatic cancer	0.000426	0.00461	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—SHH—pancreatic cancer	0.000405	0.00438	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PRLHR—pancreatic cancer	0.000404	0.00437	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—IAPP—pancreatic cancer	0.0004	0.00433	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—AGTR1—pancreatic cancer	0.000392	0.00424	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—PTCH1—pancreatic cancer	0.000384	0.00416	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—PTHLH—pancreatic cancer	0.000384	0.00416	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GLP1R—pancreatic cancer	0.000381	0.00412	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—SSTR3—pancreatic cancer	0.000378	0.00409	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PRSS1—pancreatic cancer	0.000378	0.00409	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—DPYD—pancreatic cancer	0.000375	0.00405	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GDI1—pancreatic cancer	0.00037	0.004	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GDI2—pancreatic cancer	0.00037	0.004	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—SSTR1—pancreatic cancer	0.000362	0.00392	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—SLC2A2—pancreatic cancer	0.000356	0.00385	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PPY—pancreatic cancer	0.000355	0.00384	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—SST—pancreatic cancer	0.000351	0.0038	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—SSTR2—pancreatic cancer	0.000349	0.00377	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—SSTR3—pancreatic cancer	0.000343	0.00371	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CCKBR—pancreatic cancer	0.000337	0.00364	CbGpPWpGaD
Gabapentin—ADORA1—Circadian rythm related genes—PPARG—pancreatic cancer	0.000336	0.00363	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—SSTR1—pancreatic cancer	0.000329	0.00356	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—ARG2—pancreatic cancer	0.000328	0.00354	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CNR1—pancreatic cancer	0.000324	0.00351	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PPY—pancreatic cancer	0.000323	0.00349	CbGpPWpGaD
Gabapentin—CACNA1B—Transmission across Chemical Synapses—HRAS—pancreatic cancer	0.000321	0.00347	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—SSTR2—pancreatic cancer	0.000317	0.00343	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—GCG—pancreatic cancer	0.000313	0.00339	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CCKBR—pancreatic cancer	0.000306	0.00331	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—AGTR1—pancreatic cancer	0.000299	0.00323	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—GAST—pancreatic cancer	0.00029	0.00313	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—TYMP—pancreatic cancer	0.000286	0.0031	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—CD44—pancreatic cancer	0.000275	0.00298	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—SCT—pancreatic cancer	0.000275	0.00297	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—GCG—pancreatic cancer	0.000264	0.00286	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—GAST—pancreatic cancer	0.000263	0.00285	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CCK—pancreatic cancer	0.000262	0.00283	CbGpPWpGaD
Gabapentin—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00026	0.000286	CcSEcCtD
Gabapentin—Oedema—Docetaxel—pancreatic cancer	0.00026	0.000286	CcSEcCtD
Gabapentin—Weight increased—Doxorubicin—pancreatic cancer	0.000259	0.000286	CcSEcCtD
Gabapentin—Epistaxis—Epirubicin—pancreatic cancer	0.000259	0.000285	CcSEcCtD
Gabapentin—Pruritus—Gemcitabine—pancreatic cancer	0.000259	0.000285	CcSEcCtD
Gabapentin—Infection—Docetaxel—pancreatic cancer	0.000258	0.000284	CcSEcCtD
Gabapentin—Weight decreased—Doxorubicin—pancreatic cancer	0.000258	0.000284	CcSEcCtD
Gabapentin—Sinusitis—Epirubicin—pancreatic cancer	0.000258	0.000284	CcSEcCtD
Gabapentin—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000257	0.000283	CcSEcCtD
Gabapentin—Diarrhoea—Irinotecan—pancreatic cancer	0.000257	0.000283	CcSEcCtD
Gabapentin—Pneumonia—Doxorubicin—pancreatic cancer	0.000255	0.000281	CcSEcCtD
Gabapentin—Shock—Docetaxel—pancreatic cancer	0.000255	0.000281	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—CNR2—pancreatic cancer	0.000255	0.00276	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—GLP1R—pancreatic cancer	0.000255	0.00276	CbGpPWpGaD
Gabapentin—Nervous system disorder—Docetaxel—pancreatic cancer	0.000255	0.00028	CcSEcCtD
Gabapentin—Pruritus—Fluorouracil—pancreatic cancer	0.000254	0.00028	CcSEcCtD
Gabapentin—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000254	0.00028	CcSEcCtD
Gabapentin—Infestation NOS—Doxorubicin—pancreatic cancer	0.000254	0.00028	CcSEcCtD
Gabapentin—Infestation—Doxorubicin—pancreatic cancer	0.000254	0.00028	CcSEcCtD
Gabapentin—Drowsiness—Doxorubicin—pancreatic cancer	0.000254	0.00028	CcSEcCtD
Gabapentin—Tachycardia—Docetaxel—pancreatic cancer	0.000253	0.000279	CcSEcCtD
Gabapentin—Skin disorder—Docetaxel—pancreatic cancer	0.000252	0.000278	CcSEcCtD
Gabapentin—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000252	0.000277	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—CCKAR—pancreatic cancer	0.000251	0.00272	CbGpPWpGaD
Gabapentin—Bradycardia—Epirubicin—pancreatic cancer	0.000251	0.000276	CcSEcCtD
Gabapentin—Diarrhoea—Gemcitabine—pancreatic cancer	0.00025	0.000276	CcSEcCtD
Gabapentin—Renal failure—Doxorubicin—pancreatic cancer	0.00025	0.000275	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—SCT—pancreatic cancer	0.000249	0.0027	CbGpPWpGaD
Gabapentin—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000249	0.000274	CcSEcCtD
Gabapentin—Dizziness—Irinotecan—pancreatic cancer	0.000248	0.000274	CcSEcCtD
Gabapentin—BCAT1—Metabolism—STK11—pancreatic cancer	0.000248	0.00269	CbGpPWpGaD
Gabapentin—Stomatitis—Doxorubicin—pancreatic cancer	0.000248	0.000273	CcSEcCtD
Gabapentin—Jaundice—Doxorubicin—pancreatic cancer	0.000248	0.000273	CcSEcCtD
Gabapentin—Anorexia—Docetaxel—pancreatic cancer	0.000247	0.000273	CcSEcCtD
Gabapentin—Rhinitis—Epirubicin—pancreatic cancer	0.000247	0.000272	CcSEcCtD
Gabapentin—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000247	0.000272	CcSEcCtD
Gabapentin—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000247	0.000272	CcSEcCtD
Gabapentin—Haemorrhage—Epirubicin—pancreatic cancer	0.000246	0.000272	CcSEcCtD
Gabapentin—Hepatitis—Epirubicin—pancreatic cancer	0.000246	0.000272	CcSEcCtD
Gabapentin—Diarrhoea—Fluorouracil—pancreatic cancer	0.000246	0.000271	CcSEcCtD
Gabapentin—CACNA1B—Neuronal System—HRAS—pancreatic cancer	0.000246	0.00266	CbGpPWpGaD
Gabapentin—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000245	0.00027	CcSEcCtD
Gabapentin—Pharyngitis—Epirubicin—pancreatic cancer	0.000245	0.000269	CcSEcCtD
Gabapentin—Sweating—Doxorubicin—pancreatic cancer	0.000243	0.000268	CcSEcCtD
Gabapentin—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000243	0.000268	CcSEcCtD
Gabapentin—Oedema peripheral—Epirubicin—pancreatic cancer	0.000243	0.000267	CcSEcCtD
Gabapentin—Hypotension—Docetaxel—pancreatic cancer	0.000243	0.000267	CcSEcCtD
Gabapentin—Haematuria—Doxorubicin—pancreatic cancer	0.000242	0.000267	CcSEcCtD
Gabapentin—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000242	0.000267	CcSEcCtD
Gabapentin—Urethral disorder—Epirubicin—pancreatic cancer	0.000242	0.000266	CcSEcCtD
Gabapentin—Hepatobiliary disease—Doxorubicin—pancreatic cancer	0.00024	0.000265	CcSEcCtD
Gabapentin—Epistaxis—Doxorubicin—pancreatic cancer	0.00024	0.000264	CcSEcCtD
Gabapentin—Vomiting—Irinotecan—pancreatic cancer	0.000239	0.000263	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—PRLHR—pancreatic cancer	0.000238	0.00258	CbGpPWpGaD
Gabapentin—Sinusitis—Doxorubicin—pancreatic cancer	0.000238	0.000263	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—CCK—pancreatic cancer	0.000238	0.00257	CbGpPWpGaD
Gabapentin—Dizziness—Fluorouracil—pancreatic cancer	0.000238	0.000262	CcSEcCtD
Gabapentin—Visual impairment—Epirubicin—pancreatic cancer	0.000237	0.000262	CcSEcCtD
Gabapentin—Rash—Irinotecan—pancreatic cancer	0.000237	0.000261	CcSEcCtD
Gabapentin—Dermatitis—Irinotecan—pancreatic cancer	0.000237	0.000261	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000236	0.000261	CcSEcCtD
Gabapentin—Headache—Irinotecan—pancreatic cancer	0.000235	0.000259	CcSEcCtD
Gabapentin—Insomnia—Docetaxel—pancreatic cancer	0.000235	0.000259	CcSEcCtD
Gabapentin—Paraesthesia—Docetaxel—pancreatic cancer	0.000233	0.000257	CcSEcCtD
Gabapentin—Erythema multiforme—Epirubicin—pancreatic cancer	0.000233	0.000257	CcSEcCtD
Gabapentin—Vomiting—Gemcitabine—pancreatic cancer	0.000233	0.000256	CcSEcCtD
Gabapentin—Bradycardia—Doxorubicin—pancreatic cancer	0.000232	0.000256	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—CNR2—pancreatic cancer	0.000232	0.00251	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—GLP1R—pancreatic cancer	0.000232	0.00251	CbGpPWpGaD
Gabapentin—Dyspnoea—Docetaxel—pancreatic cancer	0.000231	0.000255	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—GLP1R—pancreatic cancer	0.000231	0.0025	CbGpPWpGaD
Gabapentin—Somnolence—Docetaxel—pancreatic cancer	0.000231	0.000254	CcSEcCtD
Gabapentin—Rash—Gemcitabine—pancreatic cancer	0.000231	0.000254	CcSEcCtD
Gabapentin—Dermatitis—Gemcitabine—pancreatic cancer	0.00023	0.000254	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—PTEN—pancreatic cancer	0.00023	0.00249	CbGpPWpGaD
Gabapentin—Eye disorder—Epirubicin—pancreatic cancer	0.00023	0.000254	CcSEcCtD
Gabapentin—Tinnitus—Epirubicin—pancreatic cancer	0.00023	0.000253	CcSEcCtD
Gabapentin—Headache—Gemcitabine—pancreatic cancer	0.000229	0.000252	CcSEcCtD
Gabapentin—Cardiac disorder—Epirubicin—pancreatic cancer	0.000229	0.000252	CcSEcCtD
Gabapentin—Vomiting—Fluorouracil—pancreatic cancer	0.000229	0.000252	CcSEcCtD
Gabapentin—Rhinitis—Doxorubicin—pancreatic cancer	0.000229	0.000252	CcSEcCtD
Gabapentin—Dyspepsia—Docetaxel—pancreatic cancer	0.000228	0.000252	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—CCKAR—pancreatic cancer	0.000228	0.00247	CbGpPWpGaD
Gabapentin—Hepatitis—Doxorubicin—pancreatic cancer	0.000228	0.000251	CcSEcCtD
Gabapentin—Haemorrhage—Doxorubicin—pancreatic cancer	0.000228	0.000251	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—DPYD—pancreatic cancer	0.000227	0.00246	CbGpPWpGaD
Gabapentin—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000227	0.00025	CcSEcCtD
Gabapentin—Rash—Fluorouracil—pancreatic cancer	0.000227	0.00025	CcSEcCtD
Gabapentin—Dermatitis—Fluorouracil—pancreatic cancer	0.000227	0.00025	CcSEcCtD
Gabapentin—Pharyngitis—Doxorubicin—pancreatic cancer	0.000226	0.000249	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—IAPP—pancreatic cancer	0.000226	0.00245	CbGpPWpGaD
Gabapentin—ADORA1—G alpha (i) signalling events—CXCL8—pancreatic cancer	0.000226	0.00245	CbGpPWpGaD
Gabapentin—Decreased appetite—Docetaxel—pancreatic cancer	0.000226	0.000249	CcSEcCtD
Gabapentin—Headache—Fluorouracil—pancreatic cancer	0.000225	0.000248	CcSEcCtD
Gabapentin—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000225	0.000248	CcSEcCtD
Gabapentin—Oedema peripheral—Doxorubicin—pancreatic cancer	0.000225	0.000247	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—ACVR1B—pancreatic cancer	0.000224	0.00243	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—ZNRF3—pancreatic cancer	0.000224	0.00243	CbGpPWpGaD
Gabapentin—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000224	0.000247	CcSEcCtD
Gabapentin—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000224	0.000247	CcSEcCtD
Gabapentin—Fatigue—Docetaxel—pancreatic cancer	0.000224	0.000247	CcSEcCtD
Gabapentin—Urethral disorder—Doxorubicin—pancreatic cancer	0.000224	0.000246	CcSEcCtD
Gabapentin—Nausea—Irinotecan—pancreatic cancer	0.000223	0.000246	CcSEcCtD
Gabapentin—Immune system disorder—Epirubicin—pancreatic cancer	0.000223	0.000245	CcSEcCtD
Gabapentin—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000222	0.000245	CcSEcCtD
Gabapentin—Pain—Docetaxel—pancreatic cancer	0.000222	0.000245	CcSEcCtD
Gabapentin—Constipation—Docetaxel—pancreatic cancer	0.000222	0.000245	CcSEcCtD
Gabapentin—Chills—Epirubicin—pancreatic cancer	0.000221	0.000244	CcSEcCtD
Gabapentin—Visual impairment—Doxorubicin—pancreatic cancer	0.00022	0.000242	CcSEcCtD
Gabapentin—Alopecia—Epirubicin—pancreatic cancer	0.000218	0.00024	CcSEcCtD
Gabapentin—Nausea—Gemcitabine—pancreatic cancer	0.000217	0.000239	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—PTHLH—pancreatic cancer	0.000217	0.00235	CbGpPWpGaD
Gabapentin—Mental disorder—Epirubicin—pancreatic cancer	0.000216	0.000238	CcSEcCtD
Gabapentin—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000216	0.000238	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—SLC2A2—pancreatic cancer	0.000215	0.00233	CbGpPWpGaD
Gabapentin—Malnutrition—Epirubicin—pancreatic cancer	0.000215	0.000236	CcSEcCtD
Gabapentin—Erythema—Epirubicin—pancreatic cancer	0.000215	0.000236	CcSEcCtD
Gabapentin—Feeling abnormal—Docetaxel—pancreatic cancer	0.000214	0.000236	CcSEcCtD
Gabapentin—Nausea—Fluorouracil—pancreatic cancer	0.000214	0.000235	CcSEcCtD
Gabapentin—BCAT1—Metabolism—TYMS—pancreatic cancer	0.000214	0.00231	CbGpPWpGaD
Gabapentin—Eye disorder—Doxorubicin—pancreatic cancer	0.000213	0.000235	CcSEcCtD
Gabapentin—CACNA2D2—Transmission across Chemical Synapses—HRAS—pancreatic cancer	0.000213	0.0023	CbGpPWpGaD
Gabapentin—Tinnitus—Doxorubicin—pancreatic cancer	0.000213	0.000234	CcSEcCtD
Gabapentin—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000212	0.000234	CcSEcCtD
Gabapentin—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000212	0.000233	CcSEcCtD
Gabapentin—Flatulence—Epirubicin—pancreatic cancer	0.000211	0.000233	CcSEcCtD
Gabapentin—Tension—Epirubicin—pancreatic cancer	0.00021	0.000232	CcSEcCtD
Gabapentin—Dysgeusia—Epirubicin—pancreatic cancer	0.00021	0.000231	CcSEcCtD
Gabapentin—Nervousness—Epirubicin—pancreatic cancer	0.000208	0.00023	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—SHH—pancreatic cancer	0.000208	0.00225	CbGpPWpGaD
Gabapentin—Back pain—Epirubicin—pancreatic cancer	0.000207	0.000229	CcSEcCtD
Gabapentin—Muscle spasms—Epirubicin—pancreatic cancer	0.000206	0.000227	CcSEcCtD
Gabapentin—Immune system disorder—Doxorubicin—pancreatic cancer	0.000206	0.000227	CcSEcCtD
Gabapentin—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000205	0.000226	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—IAPP—pancreatic cancer	0.000205	0.00222	CbGpPWpGaD
Gabapentin—Abdominal pain—Docetaxel—pancreatic cancer	0.000205	0.000226	CcSEcCtD
Gabapentin—Body temperature increased—Docetaxel—pancreatic cancer	0.000205	0.000226	CcSEcCtD
Gabapentin—Chills—Doxorubicin—pancreatic cancer	0.000205	0.000225	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—SSTR3—pancreatic cancer	0.000203	0.00219	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—DTX1—pancreatic cancer	0.000203	0.00219	CbGpPWpGaD
Gabapentin—Vision blurred—Epirubicin—pancreatic cancer	0.000202	0.000223	CcSEcCtD
Gabapentin—Alopecia—Doxorubicin—pancreatic cancer	0.000201	0.000222	CcSEcCtD
Gabapentin—Mental disorder—Doxorubicin—pancreatic cancer	0.0002	0.00022	CcSEcCtD
Gabapentin—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000199	0.000219	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—SST—pancreatic cancer	0.000199	0.00215	CbGpPWpGaD
Gabapentin—Erythema—Doxorubicin—pancreatic cancer	0.000198	0.000219	CcSEcCtD
Gabapentin—Malnutrition—Doxorubicin—pancreatic cancer	0.000198	0.000219	CcSEcCtD
Gabapentin—Anaemia—Epirubicin—pancreatic cancer	0.000198	0.000218	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—PTHLH—pancreatic cancer	0.000197	0.00213	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PTCH1—pancreatic cancer	0.000197	0.00213	CbGpPWpGaD
Gabapentin—Agitation—Epirubicin—pancreatic cancer	0.000197	0.000217	CcSEcCtD
Gabapentin—Flatulence—Doxorubicin—pancreatic cancer	0.000196	0.000215	CcSEcCtD
Gabapentin—Tension—Doxorubicin—pancreatic cancer	0.000195	0.000215	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—SSTR1—pancreatic cancer	0.000194	0.0021	CbGpPWpGaD
Gabapentin—Dysgeusia—Doxorubicin—pancreatic cancer	0.000194	0.000214	CcSEcCtD
Gabapentin—Malaise—Epirubicin—pancreatic cancer	0.000193	0.000213	CcSEcCtD
Gabapentin—Nervousness—Doxorubicin—pancreatic cancer	0.000193	0.000212	CcSEcCtD
Gabapentin—Vertigo—Epirubicin—pancreatic cancer	0.000193	0.000212	CcSEcCtD
Gabapentin—Syncope—Epirubicin—pancreatic cancer	0.000192	0.000212	CcSEcCtD
Gabapentin—Leukopenia—Epirubicin—pancreatic cancer	0.000192	0.000212	CcSEcCtD
Gabapentin—Back pain—Doxorubicin—pancreatic cancer	0.000192	0.000212	CcSEcCtD
Gabapentin—Hypersensitivity—Docetaxel—pancreatic cancer	0.000191	0.000211	CcSEcCtD
Gabapentin—Muscle spasms—Doxorubicin—pancreatic cancer	0.000191	0.00021	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—PPY—pancreatic cancer	0.000191	0.00206	CbGpPWpGaD
Gabapentin—Palpitations—Epirubicin—pancreatic cancer	0.00019	0.000209	CcSEcCtD
Gabapentin—Loss of consciousness—Epirubicin—pancreatic cancer	0.000189	0.000208	CcSEcCtD
Gabapentin—Cough—Epirubicin—pancreatic cancer	0.000187	0.000206	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—SSTR2—pancreatic cancer	0.000187	0.00202	CbGpPWpGaD
Gabapentin—Vision blurred—Doxorubicin—pancreatic cancer	0.000187	0.000206	CcSEcCtD
Gabapentin—Asthenia—Docetaxel—pancreatic cancer	0.000186	0.000205	CcSEcCtD
Gabapentin—Convulsion—Epirubicin—pancreatic cancer	0.000186	0.000205	CcSEcCtD
Gabapentin—Hypertension—Epirubicin—pancreatic cancer	0.000185	0.000204	CcSEcCtD
Gabapentin—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000184	0.000203	CcSEcCtD
Gabapentin—Pruritus—Docetaxel—pancreatic cancer	0.000184	0.000202	CcSEcCtD
Gabapentin—Anaemia—Doxorubicin—pancreatic cancer	0.000183	0.000202	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—CNR1—pancreatic cancer	0.000183	0.00198	CbGpPWpGaD
Gabapentin—Myalgia—Epirubicin—pancreatic cancer	0.000183	0.000201	CcSEcCtD
Gabapentin—Arthralgia—Epirubicin—pancreatic cancer	0.000183	0.000201	CcSEcCtD
Gabapentin—Chest pain—Epirubicin—pancreatic cancer	0.000183	0.000201	CcSEcCtD
Gabapentin—Agitation—Doxorubicin—pancreatic cancer	0.000182	0.000201	CcSEcCtD
Gabapentin—Anxiety—Epirubicin—pancreatic cancer	0.000182	0.000201	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000181	0.0002	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—CCKBR—pancreatic cancer	0.000181	0.00196	CbGpPWpGaD
Gabapentin—Discomfort—Epirubicin—pancreatic cancer	0.00018	0.000199	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—SST—pancreatic cancer	0.00018	0.00195	CbGpPWpGaD
Gabapentin—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	0.00018	0.00194	CbGpPWpGaD
Gabapentin—Malaise—Doxorubicin—pancreatic cancer	0.000179	0.000197	CcSEcCtD
Gabapentin—Dry mouth—Epirubicin—pancreatic cancer	0.000179	0.000197	CcSEcCtD
Gabapentin—Vertigo—Doxorubicin—pancreatic cancer	0.000178	0.000196	CcSEcCtD
Gabapentin—Syncope—Doxorubicin—pancreatic cancer	0.000178	0.000196	CcSEcCtD
Gabapentin—Leukopenia—Doxorubicin—pancreatic cancer	0.000178	0.000196	CcSEcCtD
Gabapentin—Diarrhoea—Docetaxel—pancreatic cancer	0.000178	0.000196	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—GCG—pancreatic cancer	0.000177	0.00191	CbGpPWpGaD
Gabapentin—Confusional state—Epirubicin—pancreatic cancer	0.000177	0.000194	CcSEcCtD
Gabapentin—Palpitations—Doxorubicin—pancreatic cancer	0.000175	0.000193	CcSEcCtD
Gabapentin—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000175	0.000193	CcSEcCtD
Gabapentin—Oedema—Epirubicin—pancreatic cancer	0.000175	0.000193	CcSEcCtD
Gabapentin—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000174	0.000192	CcSEcCtD
Gabapentin—Infection—Epirubicin—pancreatic cancer	0.000174	0.000192	CcSEcCtD
Gabapentin—BCAT1—Metabolism—APOE—pancreatic cancer	0.000174	0.00188	CbGpPWpGaD
Gabapentin—Cough—Doxorubicin—pancreatic cancer	0.000173	0.000191	CcSEcCtD
Gabapentin—Shock—Epirubicin—pancreatic cancer	0.000172	0.00019	CcSEcCtD
Gabapentin—Convulsion—Doxorubicin—pancreatic cancer	0.000172	0.000189	CcSEcCtD
Gabapentin—Nervous system disorder—Epirubicin—pancreatic cancer	0.000172	0.000189	CcSEcCtD
Gabapentin—Dizziness—Docetaxel—pancreatic cancer	0.000172	0.000189	CcSEcCtD
Gabapentin—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000171	0.000189	CcSEcCtD
Gabapentin—Hypertension—Doxorubicin—pancreatic cancer	0.000171	0.000189	CcSEcCtD
Gabapentin—Tachycardia—Epirubicin—pancreatic cancer	0.000171	0.000188	CcSEcCtD
Gabapentin—Skin disorder—Epirubicin—pancreatic cancer	0.00017	0.000187	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—DTX4—pancreatic cancer	0.00017	0.00184	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GLI1—pancreatic cancer	0.00017	0.00184	CbGpPWpGaD
Gabapentin—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000169	0.000186	CcSEcCtD
Gabapentin—Myalgia—Doxorubicin—pancreatic cancer	0.000169	0.000186	CcSEcCtD
Gabapentin—Arthralgia—Doxorubicin—pancreatic cancer	0.000169	0.000186	CcSEcCtD
Gabapentin—Chest pain—Doxorubicin—pancreatic cancer	0.000169	0.000186	CcSEcCtD
Gabapentin—ADORA1—GPCR downstream signaling—AGTR1—pancreatic cancer	0.000169	0.00183	CbGpPWpGaD
Gabapentin—Anxiety—Doxorubicin—pancreatic cancer	0.000168	0.000186	CcSEcCtD
Gabapentin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000168	0.000185	CcSEcCtD
Gabapentin—Discomfort—Doxorubicin—pancreatic cancer	0.000167	0.000184	CcSEcCtD
Gabapentin—Anorexia—Epirubicin—pancreatic cancer	0.000167	0.000184	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—CD44—pancreatic cancer	0.000167	0.00181	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CNR1—pancreatic cancer	0.000166	0.0018	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NRP1—pancreatic cancer	0.000165	0.00179	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PPP2R5B—pancreatic cancer	0.000165	0.00179	CbGpPWpGaD
Gabapentin—Dry mouth—Doxorubicin—pancreatic cancer	0.000165	0.000182	CcSEcCtD
Gabapentin—Vomiting—Docetaxel—pancreatic cancer	0.000165	0.000182	CcSEcCtD
Gabapentin—Rash—Docetaxel—pancreatic cancer	0.000164	0.00018	CcSEcCtD
Gabapentin—Hypotension—Epirubicin—pancreatic cancer	0.000164	0.00018	CcSEcCtD
Gabapentin—Dermatitis—Docetaxel—pancreatic cancer	0.000164	0.00018	CcSEcCtD
Gabapentin—Confusional state—Doxorubicin—pancreatic cancer	0.000163	0.00018	CcSEcCtD
Gabapentin—CACNA2D2—Neuronal System—HRAS—pancreatic cancer	0.000163	0.00176	CbGpPWpGaD
Gabapentin—Headache—Docetaxel—pancreatic cancer	0.000163	0.000179	CcSEcCtD
Gabapentin—Oedema—Doxorubicin—pancreatic cancer	0.000162	0.000178	CcSEcCtD
Gabapentin—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000162	0.000178	CcSEcCtD
Gabapentin—Infection—Doxorubicin—pancreatic cancer	0.000161	0.000177	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—GCG—pancreatic cancer	0.000161	0.00174	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—GCG—pancreatic cancer	0.00016	0.00173	CbGpPWpGaD
Gabapentin—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000159	0.000176	CcSEcCtD
Gabapentin—Shock—Doxorubicin—pancreatic cancer	0.000159	0.000176	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—HEY2—pancreatic cancer	0.000159	0.00172	CbGpPWpGaD
Gabapentin—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000159	0.000175	CcSEcCtD
Gabapentin—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000159	0.000175	CcSEcCtD
Gabapentin—Insomnia—Epirubicin—pancreatic cancer	0.000158	0.000174	CcSEcCtD
Gabapentin—Tachycardia—Doxorubicin—pancreatic cancer	0.000158	0.000174	CcSEcCtD
Gabapentin—Skin disorder—Doxorubicin—pancreatic cancer	0.000157	0.000173	CcSEcCtD
Gabapentin—ADORA1—Circadian rythm related genes—TP53—pancreatic cancer	0.000157	0.0017	CbGpPWpGaD
Gabapentin—Paraesthesia—Epirubicin—pancreatic cancer	0.000157	0.000173	CcSEcCtD
Gabapentin—BCAT1—Metabolism—PIK3CG—pancreatic cancer	0.000157	0.0017	CbGpPWpGaD
Gabapentin—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000157	0.000173	CcSEcCtD
Gabapentin—Dyspnoea—Epirubicin—pancreatic cancer	0.000156	0.000172	CcSEcCtD
Gabapentin—Somnolence—Epirubicin—pancreatic cancer	0.000156	0.000171	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—GAST—pancreatic cancer	0.000155	0.00168	CbGpPWpGaD
Gabapentin—Anorexia—Doxorubicin—pancreatic cancer	0.000154	0.00017	CcSEcCtD
Gabapentin—Nausea—Docetaxel—pancreatic cancer	0.000154	0.00017	CcSEcCtD
Gabapentin—Dyspepsia—Epirubicin—pancreatic cancer	0.000154	0.00017	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—AGTR1—pancreatic cancer	0.000153	0.00166	CbGpPWpGaD
Gabapentin—Decreased appetite—Epirubicin—pancreatic cancer	0.000152	0.000168	CcSEcCtD
Gabapentin—Hypotension—Doxorubicin—pancreatic cancer	0.000151	0.000167	CcSEcCtD
Gabapentin—BCAT1—Metabolism—PPARG—pancreatic cancer	0.000151	0.00164	CbGpPWpGaD
Gabapentin—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000151	0.000167	CcSEcCtD
Gabapentin—Fatigue—Epirubicin—pancreatic cancer	0.000151	0.000166	CcSEcCtD
Gabapentin—CACNA2D2—Metabolism—STK11—pancreatic cancer	0.00015	0.00163	CbGpPWpGaD
Gabapentin—Constipation—Epirubicin—pancreatic cancer	0.00015	0.000165	CcSEcCtD
Gabapentin—Pain—Epirubicin—pancreatic cancer	0.00015	0.000165	CcSEcCtD
Gabapentin—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000148	0.000163	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—SCT—pancreatic cancer	0.000147	0.00159	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HEY1—pancreatic cancer	0.000147	0.00159	CbGpPWpGaD
Gabapentin—Insomnia—Doxorubicin—pancreatic cancer	0.000147	0.000161	CcSEcCtD
Gabapentin—Paraesthesia—Doxorubicin—pancreatic cancer	0.000145	0.00016	CcSEcCtD
Gabapentin—Dyspnoea—Doxorubicin—pancreatic cancer	0.000144	0.000159	CcSEcCtD
Gabapentin—Feeling abnormal—Epirubicin—pancreatic cancer	0.000144	0.000159	CcSEcCtD
Gabapentin—Somnolence—Doxorubicin—pancreatic cancer	0.000144	0.000159	CcSEcCtD
Gabapentin—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000143	0.000158	CcSEcCtD
Gabapentin—Dyspepsia—Doxorubicin—pancreatic cancer	0.000143	0.000157	CcSEcCtD
Gabapentin—Decreased appetite—Doxorubicin—pancreatic cancer	0.000141	0.000155	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—CCK—pancreatic cancer	0.000141	0.00152	CbGpPWpGaD
Gabapentin—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.00014	0.000154	CcSEcCtD
Gabapentin—Fatigue—Doxorubicin—pancreatic cancer	0.00014	0.000154	CcSEcCtD
Gabapentin—Urticaria—Epirubicin—pancreatic cancer	0.000139	0.000153	CcSEcCtD
Gabapentin—Constipation—Doxorubicin—pancreatic cancer	0.000139	0.000153	CcSEcCtD
Gabapentin—Pain—Doxorubicin—pancreatic cancer	0.000139	0.000153	CcSEcCtD
Gabapentin—Abdominal pain—Epirubicin—pancreatic cancer	0.000138	0.000152	CcSEcCtD
Gabapentin—Body temperature increased—Epirubicin—pancreatic cancer	0.000138	0.000152	CcSEcCtD
Gabapentin—BCAT1—Metabolism—PIK3CD—pancreatic cancer	0.000138	0.00149	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CNR2—pancreatic cancer	0.000137	0.00148	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GLP1R—pancreatic cancer	0.000137	0.00148	CbGpPWpGaD
Gabapentin—ADORA1—GPCR ligand binding—CXCL8—pancreatic cancer	0.000137	0.00148	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCKAR—pancreatic cancer	0.000135	0.00146	CbGpPWpGaD
Gabapentin—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000133	0.000147	CcSEcCtD
Gabapentin—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000132	0.000146	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—JAG2—pancreatic cancer	0.000131	0.00141	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—TYMS—pancreatic cancer	0.000129	0.0014	CbGpPWpGaD
Gabapentin—Hypersensitivity—Epirubicin—pancreatic cancer	0.000129	0.000142	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—MEN1—pancreatic cancer	0.000129	0.00139	CbGpPWpGaD
Gabapentin—Urticaria—Doxorubicin—pancreatic cancer	0.000129	0.000142	CcSEcCtD
Gabapentin—Body temperature increased—Doxorubicin—pancreatic cancer	0.000128	0.000141	CcSEcCtD
Gabapentin—Abdominal pain—Doxorubicin—pancreatic cancer	0.000128	0.000141	CcSEcCtD
Gabapentin—Asthenia—Epirubicin—pancreatic cancer	0.000126	0.000138	CcSEcCtD
Gabapentin—Pruritus—Epirubicin—pancreatic cancer	0.000124	0.000136	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—SHH—pancreatic cancer	0.000123	0.00133	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NOTCH4—pancreatic cancer	0.000122	0.00132	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—IAPP—pancreatic cancer	0.000121	0.00131	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3CB—pancreatic cancer	0.00012	0.0013	CbGpPWpGaD
Gabapentin—Diarrhoea—Epirubicin—pancreatic cancer	0.00012	0.000132	CcSEcCtD
Gabapentin—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000119	0.000131	CcSEcCtD
Gabapentin—BCAT1—Metabolism—PTGS2—pancreatic cancer	0.000119	0.00129	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PTCH1—pancreatic cancer	0.000116	0.00126	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PTHLH—pancreatic cancer	0.000116	0.00126	CbGpPWpGaD
Gabapentin—Asthenia—Doxorubicin—pancreatic cancer	0.000116	0.000128	CcSEcCtD
Gabapentin—Dizziness—Epirubicin—pancreatic cancer	0.000116	0.000128	CcSEcCtD
Gabapentin—Pruritus—Doxorubicin—pancreatic cancer	0.000115	0.000126	CcSEcCtD
Gabapentin—Vomiting—Epirubicin—pancreatic cancer	0.000111	0.000123	CcSEcCtD
Gabapentin—Diarrhoea—Doxorubicin—pancreatic cancer	0.000111	0.000122	CcSEcCtD
Gabapentin—Rash—Epirubicin—pancreatic cancer	0.00011	0.000122	CcSEcCtD
Gabapentin—Dermatitis—Epirubicin—pancreatic cancer	0.00011	0.000122	CcSEcCtD
Gabapentin—Headache—Epirubicin—pancreatic cancer	0.00011	0.000121	CcSEcCtD
Gabapentin—Dizziness—Doxorubicin—pancreatic cancer	0.000107	0.000118	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—SST—pancreatic cancer	0.000107	0.00115	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—APOE—pancreatic cancer	0.000105	0.00114	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CG—pancreatic cancer	0.000105	0.00114	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—JAG1—pancreatic cancer	0.000104	0.00113	CbGpPWpGaD
Gabapentin—Nausea—Epirubicin—pancreatic cancer	0.000104	0.000115	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—NOTCH3—pancreatic cancer	0.000104	0.00112	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PTEN—pancreatic cancer	0.000104	0.00112	CbGpPWpGaD
Gabapentin—Vomiting—Doxorubicin—pancreatic cancer	0.000103	0.000113	CcSEcCtD
Gabapentin—Rash—Doxorubicin—pancreatic cancer	0.000102	0.000113	CcSEcCtD
Gabapentin—Dermatitis—Doxorubicin—pancreatic cancer	0.000102	0.000112	CcSEcCtD
Gabapentin—Headache—Doxorubicin—pancreatic cancer	0.000101	0.000112	CcSEcCtD
Gabapentin—ADORA1—Signaling Pathways—CNR1—pancreatic cancer	9.83e-05	0.00106	CbGpPWpGaD
Gabapentin—Nausea—Doxorubicin—pancreatic cancer	9.62e-05	0.000106	CcSEcCtD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CG—pancreatic cancer	9.54e-05	0.00103	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIK3CG—pancreatic cancer	9.5e-05	0.00103	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—GCG—pancreatic cancer	9.49e-05	0.00103	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CD—pancreatic cancer	9.23e-05	0.000999	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PPARG—pancreatic cancer	9.17e-05	0.000992	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AGTR1—pancreatic cancer	9.06e-05	0.00098	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—STK11—pancreatic cancer	8.93e-05	0.000966	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CD—pancreatic cancer	8.39e-05	0.000907	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIK3CD—pancreatic cancer	8.35e-05	0.000903	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CB—pancreatic cancer	8.05e-05	0.000871	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SMAD4—pancreatic cancer	7.82e-05	0.000846	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—CXCL8—pancreatic cancer	7.74e-05	0.000837	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HES1—pancreatic cancer	7.63e-05	0.000826	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—PIK3CA—pancreatic cancer	7.32e-05	0.000792	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CB—pancreatic cancer	7.31e-05	0.000791	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIK3CB—pancreatic cancer	7.28e-05	0.000787	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PTGS2—pancreatic cancer	7.21e-05	0.00078	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—CXCL8—pancreatic cancer	7.02e-05	0.00076	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TERT—pancreatic cancer	6.69e-05	0.000724	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HIF1A—pancreatic cancer	6.4e-05	0.000692	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TSC2—pancreatic cancer	6.38e-05	0.00069	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PTEN—pancreatic cancer	6.29e-05	0.00068	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—APOE—pancreatic cancer	6.24e-05	0.000676	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—KDR—pancreatic cancer	6.12e-05	0.000662	CbGpPWpGaD
Gabapentin—BCAT1—Metabolism—AKT1—pancreatic cancer	5.98e-05	0.000647	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NFKBIA—pancreatic cancer	5.82e-05	0.000629	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NOTCH1—pancreatic cancer	5.76e-05	0.000623	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PIK3CG—pancreatic cancer	5.64e-05	0.00061	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—NRAS—pancreatic cancer	5.64e-05	0.00061	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—EGF—pancreatic cancer	5.57e-05	0.000603	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—EGFR—pancreatic cancer	5.13e-05	0.000555	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PIK3CD—pancreatic cancer	4.95e-05	0.000536	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—PIK3CA—pancreatic cancer	4.91e-05	0.000531	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—KRAS—pancreatic cancer	4.85e-05	0.000525	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—PIK3CA—pancreatic cancer	4.46e-05	0.000482	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—PIK3CA—pancreatic cancer	4.44e-05	0.00048	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PIK3CB—pancreatic cancer	4.32e-05	0.000467	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CXCL8—pancreatic cancer	4.15e-05	0.000449	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—HRAS—pancreatic cancer	4.12e-05	0.000446	CbGpPWpGaD
Gabapentin—ADORA1—GPCR downstream signaling—AKT1—pancreatic cancer	4.01e-05	0.000434	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CASP3—pancreatic cancer	3.97e-05	0.00043	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CCND1—pancreatic cancer	3.87e-05	0.000418	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—CTNNB1—pancreatic cancer	3.83e-05	0.000414	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MMP9—pancreatic cancer	3.75e-05	0.000406	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PTEN—pancreatic cancer	3.73e-05	0.000404	CbGpPWpGaD
Gabapentin—ADORA1—Signaling by GPCR—AKT1—pancreatic cancer	3.64e-05	0.000394	CbGpPWpGaD
Gabapentin—CACNA2D2—Metabolism—AKT1—pancreatic cancer	3.62e-05	0.000392	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—SRC—pancreatic cancer	3.46e-05	0.000374	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—VEGFA—pancreatic cancer	3.37e-05	0.000365	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—STAT3—pancreatic cancer	3.34e-05	0.000361	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—NRAS—pancreatic cancer	3.33e-05	0.00036	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—MYC—pancreatic cancer	3.1e-05	0.000335	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TGFB1—pancreatic cancer	3.09e-05	0.000335	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—EGFR—pancreatic cancer	3.03e-05	0.000328	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—KRAS—pancreatic cancer	2.87e-05	0.00031	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—PIK3CA—pancreatic cancer	2.63e-05	0.000285	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—TP53—pancreatic cancer	2.55e-05	0.000275	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—HRAS—pancreatic cancer	2.44e-05	0.000263	CbGpPWpGaD
Gabapentin—ADORA1—Signaling Pathways—AKT1—pancreatic cancer	2.15e-05	0.000233	CbGpPWpGaD
